Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Using index funds to manage risk emphasizes broad diversification and low costs. These funds help smooth returns and reduce exposure to idiosyncratic losses.
27,240 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Joby Aviation stock surging has a few clear triggers: progress on electric air mobility, a strategic partnership with...
Cannabis stocks remain volatile and Canopy Growth sits at a crossroads in 2026. This article explains why many invest...
A 34% jump in urea prices amid Iran tensions is sending shockwaves beyond farming. This article breaks down how ferti...
A high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
As SpaceX opens trading, savvy investors wonder how much upside the IPO price may still hold. This deep-dive walks th...
A famous actress recently shared rare summer snapshots with her partner, highlighting how private moments can still s...
Crypto investment products logged $619 million in net inflows last week amid Iran tensions, with an early surge follo...
Tax policy debates often clamp down on the top earners, but targeting high earners misguided choices can undermine st...
Trump hints at government equity in AI leaders, echoing Bernie Sanders and roiling MAGA voters as markets weigh how A...
Big bet shifts by billionaire Michael Platt grab headlines as AI giants face moves from a prominent hedge fund. This ...
When policymakers hint at rate moves, investors scramble to reprice risk. This guide breaks down how an evolving inte...